ERBB2 and breast carcinoma: In patients with brain metastases, local therapies including surgical resection, stereotactic radiotherapy, or whole-brain radiotherapy are the mainstay of treatment while recent progress in systemic therapy as well as local therapy has made the approach more individualized, especially for HER2-positive breast cancer (24).